• Filing Date: 2019-02-14
  • Form Type: 10-Q
  • Description: Quarterly report
v3.10.0.1
C. STOCKHOLDERS EQUITY (Tables)
3 Months Ended
Dec. 31, 2018
Equity [Abstract]  
Stock options, stock bonuses and compensation granted by the Company

Stock options, stock bonuses and compensation granted by the Company as of December 31, 2018 are as follows:

 

Name of Plan   Total Shares Reserved Under Plans     Shares Reserved for Outstanding Options     Shares Issued     Remaining Options/Shares Under Plans  
                         
Incentive Stock Options Plans     138,400       123,558       N/A       385  
Non-Qualified Stock Option Plans     3,387,200       3,034,669       N/A       311,426  
Stock Bonus Plans     783,760       N/A       309,509       474,218  
Stock Compensation Plan     134,000       N/A       118,590       15,410  
Incentive Stock Bonus Plan     640,000       N/A       624,000       16,000  

 

Stock options, stock bonuses and compensation granted by the Company as of September 30, 2018 are as follows:

 

Name of Plan   Total Shares Reserved Under Plans     Shares Reserved for Outstanding Options     Shares Issued     Remaining Options/Shares Under Plans  
                         
Incentive Stock Option Plans     138,400       123,558       N/A       385  
Non-Qualified Stock Option Plans     3,387,200       3,036,569       N/A       309,526  
Bonus Plans     783,760       N/A       297,230       486,497  
Stock Compensation Plan     134,000       N/A       118,590       15,410  
Incentive Stock Bonus Plan     640,000       N/A       624,000       16,000  

 

Stock option activity
    Three Months Ended December 31,  
    2018     2017  
Granted     500       10,300  
Expired     2,400       17,523  
Forfeited     -       809  
Schedule of employees and non-employees stock compensation
    Three months Ended December 31,  
    2018     2017  
Employees   $ 573,660     $ 1,448,098  
Non-employees   $ 238,904     $ 42,342  
Derivative liabilities, warrants and other options
Warrant Issue Date

Shares Issuable upon Exercise

of Warrants

Exercise Price Expiration Date Reference
Series N 8/18/2008 85,339 $3.00 2/18/2020 *
Series V 5/28/2015 810,127 $19.75 5/28/2020 *
Series UU 6/11/2018 187,562    $2.80 6/11/2020 *
Series W 10/28/2015 688,930 $16.75 10/28/2020 *
Series X 1/13/2016 120,000    $9.25 1/13/2021 *
Series Y 2/15/2016 26,000 $12.00 2/15/2021 *
Series ZZ 5/23/2016 20,000 $13.75 5/18/2021 *
Series BB 8/26/2016 16,000  $13.75 8/22/2021 *
Series Z 5/23/2016 264,000 $13.75 11/23/2021 *
Series FF 12/8/2016 68,048 $3.91 12/1/2021 *
Series CC 12/8/2016 680,480 $5.00 12/8/2021 *
Series HH 2/23/2017 20,000   $3.13 2/16/2022 *
Series AA 8/26/2016 200,000 $13.75 2/22/2022 *
Series JJ 3/14/2017 30,000 $3.13 3/8/2022 *
Series LL 4/30/2017 26,398 $3.59 4/30/2022 *
Series MM 6/22/2017 893,491 $1.86 6/22/2022 *
Series NN 7/24/2017 539,300 $2.52 7/24/2022  *
Series OO 7/31/2017 60,000 $2.52 7/31/2022 *
Series QQ 8/22/2017 3,500 $2.50 8/22/2022 *
Series GG 2/23/2017 200,000 $3.00 8/23/2022 *
Series II 3/14/2017 216,500 $3.00 9/14/2022 *
Series RR 10/30/2017 555,370 $1.65 10/30/2022 *
Series KK 5/3/2017 213,870 $3.04 11/3/2022 *
Series SS 12/19/2017 807,898 $2.09 12/18/2022 2
Series TT 2/5/2018 1,210,827 $2.24 2/5/2023 2
Series PP 8/28/2017 112,500 $2.30 2/28/2023 2
Series WW 7/2/2018 195,000 $1.63 6/28/2023 *
Series VV 7/2/2018 3,900,000 $1.75 1/2/2024 *
Consultants 7/1/16 - 7/28/17 28,000 $2.18-$11.50 6/30/2019- 7/27/2027 3

 

* No current period changes to these warrants

Tabular disclosure of derivative liabilities at fair value
   

December 31,

2018

   

September 30,

2018

 
Series S warrants   $ -     $ 33  
Series V warrants     214,104       770,436  
Series W warrants     372,231       999,081  
Series Z warrants     283,646       487,767  
Series ZZ warrants     19,892       34,215  
Series AA warrants     223,255       380,474  
Series BB warrants     16,346       28,456  
Series CC warrants     1,114,118       1,779,724  
Series DD warrants     -       1,249,287  
Series EE warrants     -       1,249,287  
Series FF warrants     119,859       188,921  
Series GG warrants     394,446       607,228  
Series HH warrants     37,865       58,816  
Series II warrants     429,546       660,135  
Series JJ warrants     57,180       88,642  
Series KK warrants     428,835       656,930  
Series LL warrants     49,435       77,632  
Total warrant liabilities   $ 3,760,758     $ 9,317,064  
Schedule of gains and (losses) on derivative liabilities
    2018      2017  
Series S warrants   $ 33     $ 13,068  
Series V warrants     556,332       (98,313 )
Series W warrants     626,850       (129,467 )
Series Z warrants     204,121       (55,535 )
Series ZZ warrants     14,323       (3,343 )
Series AA warrants     157,219       (47,360 )
Series BB warrants     12,110       (2,631 )
Series CC warrants     665,606       (196,821 )
Series DD warrants     1,249,287       5,483  
Series EE warrants     1,249,287       5,483  
Series FF warrants     69,062       (18,047 )
Series GG warrants     212,782       (115,132 )
Series HH warrants     20,951       (5,662 )
Series II warrants     230,589       (178,806 )
Series JJ warrants     31,462       (8,542 )
Series KK warrants     228,095       (115,027 )
Series LL warrants     28,197       (7,578 )
Net gain (loss) on warrant liabilities   $ 5,556,306     $ (958,230 )
Exercise of equity warrants

Warrants

  Warrants Exercised     Exercise Price       Proceeds  
Series PP     60,000     $ 2.30     $ 138,000  
Series SS     152,632     $ 2.09     $ 319,001  
Series TT     86,050     $ 2.24     $ 192,752  
      298,682             $ 649,753